Skip to main content
SpringerLink
Log in
Book cover
  • Book
  • © 1993

Inhibitors of Monoamine Oxidase B

Pharmacology and Clinical Use in Neurodegenerative Disorders

Birkhäuser

Editors:

  1. I. Szelenyi

    1. Dept. of Pharmacology, ASTA Medica AG, Frankfurt/Main 1, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Milestones in Drug Therapy (MDT)

Sections

Buy it now

eBook USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (18 chapters)

  1. Front Matter

    Pages i-xviii
    PDF

  2. Parkinson’s Disease: A Brief Introduction

    1. Front Matter

      Pages 1-1
      PDF

    2. Anatomy of the Human Basal Ganglia

      • H. Braak, E. Braak
      Pages 3-23

    3. The Pathophysiological Basis of Parkinson’s Disease

      • M. Gerlach, P. Riederer
      Pages 25-50

  3. Chemistry and Pharmacology of Monoamine Oxidase B Inhibitors

    1. Front Matter

      Pages 73-73
      PDF

    3. l-Deprenyl: A Unique MAO-B Inhibitor

      • E. E. Polymeropoulos
      Pages 109-124

    7. The Mode of Action of MAO-B Inhibitors

      • M. Gerlach, P. Riederer, M. B. H. Youdim
      Pages 183-200

    8. Pharmacokinetics and Clinical Pharmacology of Selegiline

      • E. H. Heinonen, M. I. Anttila, R. A. S. Lammintausta
      Pages 201-213

    9. Preclinical Evaluation of l-Deprenyl: Lack of Amphetamine-Like Abuse Potential

      • S. Yasar, G. Winger, B. Nickel, G. Schulze, S. R. Goldberg
      Pages 215-233

  4. Clinical Experience with Monoamine Oxidase B Inhibitors

    1. Front Matter

      Pages 235-235
      PDF

    2. The History of l-Deprenyl

      • M. J. Parnham
      Pages 237-251

    6. Alzheimer’s Disease and l-Deprenyl: Rationales and Findings

      • P. N. Tariot, L. S. Schneider, S. V. Patel, B. Goldstein
      Pages 301-317
Back to top

Editors and Affiliations

  • Dept. of Pharmacology, ASTA Medica AG, Frankfurt/Main 1, Germany

    I. Szelenyi

Back to top

Bibliographic Information

  • Book Title: Inhibitors of Monoamine Oxidase B

  • Book Subtitle: Pharmacology and Clinical Use in Neurodegenerative Disorders

  • Editors: I. Szelenyi

  • Series Title: Milestones in Drug Therapy

  • DOI: https://doi.org/10.1007/978-3-0348-6348-3

  • Publisher: Birkhäuser Basel

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Basel AG 1993

  • Softcover ISBN: 978-3-0348-6349-0Published: 11 April 2014

  • eBook ISBN: 978-3-0348-6348-3Published: 12 June 2019

  • Series ISSN: 2296-6056

  • Series E-ISSN: 2296-6064

  • Edition Number: 1

  • Number of Pages: XVIII, 367

  • Number of Illustrations: 41 b/w illustrations, 2 illustrations in colour

  • Topics: Science, Humanities and Social Sciences, multidisciplinary

Back to top

Publish with us

Policies and ethics

Back to top
Access via your institution

Buy it now

eBook USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Search

Navigation